BACKGROUND The breast cancer screening (BCS) chart is suggested as a basic and preliminary tool to improve efficiency of screening mammography.
Introduction
At the present time, mammography screening is the only breast cancer screening (BCS) method that has proven to be effective. 1 Current evidence suggests that screening mammography can reduce the risk of death from breast cancer by approximately 20%. 2 There is a consensus about routine screening mammography for women aged 50-74 years. [3] [4] [5] [6] [7] However, there is inconsistency among guidelines in regard to recommendations for screening women under age 50. [3] [4] [5] [6] [7] Available guidelines recommend mammography mainly based on age. Whereas age is one out of several risk factors responsible for breast cancer, such as a personal/family history of breast cancer, known mutations of the BRCA genes, increased body mass index, estrogen-progestin hormone use, early menarche, late menopause and late age at first childbirth. 1, 4, 8, 9 Now the question is that why we do not take into account other predisposing factors of breast cancer when recommending mammography. By considering risk factors of breast cancer, it is hoped that high-risk individuals are detected easily. A screening program is more productive and efficient if it is targeted to a high-risk population, 10 otherwise it can be wasteful of resources. Evidence showed that mammography screening was not cost-effective for lower-middle income countries 11 and some other countries especially in Asia. [12] [13] [14] Several approaches have been suggested for incorporating risk factors to predict the individual risk of breast cancer. [15] [16] [17] By the targeting the high-risk individuals, the screening program becomes more efficient. The higher the risk of target population, the higher the prevalence of the disease, and the higher the positive predictive value, which is the probability of true positives among individuals who test positive. 18 On the other hand, screening a total population for a relatively infrequent disease is a wasteful use of resources and may identify only a few previously undetected cases in comparison to the amount of effort involved. Whereas, if a high-risk subset of the target population is identified and screening is directed to this group, the program is expected to be far more productive. 10 Age is certainly an important risk factor not only responsible for breast cancer but also for almost all noncommunicable diseases. However, age is across several predisposing factors of breast cancer that may help in detecting high-risk individuals. If screening mammography is directed to a highrisk subset of women, the program will probably be far more productive. It has been estimated that mammography can detect about 73% of breast cancers in women in their early 40s and 85% of breast cancers in women in their early 60s. 19 That means mammography is more productive in older age, because breast cancer is more frequent in women in the 50 and 60s. Therefore, if we identify high-risk women not only by age but also by other well-known predisposing factors and direct the screening mammography to this high-risk group of women, the screening program is more productive and efficient. This is the basic idea behind the BCS chart.
World Health Organization/International Society of Hypertension (WHO/ISH) developed WHO/ISH risk prediction chart to estimate 10-year risk of a fatal or non-fatal major cardiovascular event, according to age, sex, blood pressure, smoking status, total blood cholesterol and presence or absence of diabetes mellitus for 14 WHO epidemiological sub-regions. 20 In this study, we developed a similar chart and named it BCS chart. This chart is a basic and preliminary suggested model that can detect and stratify women who are at high risk for developing breast cancer.
Methods
The We excluded patients with unknown pathology or those who migrated elsewhere or died. We extracted data from medical records, recoded at the time of diagnosis or at the time of first visit prior to diagnosis. We obtained additional data, not included in the medical records, through interviews with patients after explaining the objectives of the study for them and taking their verbal informed consent.
We selected controls from the general population of Tehran and its suburbs. In order to increase the generalizability of the results, we divided the city into five regions, including north, south, east, west and center. Then, we selected a probability sample of the population from each region through the door-to-door approach.
We used a questionnaire included age, weight, height, age at menarche, age at first delivery, number of children, menopausal status, age at menopause, having a benign breast disease (fibrocystic disease, fibroadenomas, pseudoangiomatous stromal hyperplasia and adenosis), history of breast cancer in the first-degree relatives (mother or sister) or second/ third-degree relatives (grandmothers, aunts, nieces, or halfsisters), history of hormone replacement therapy (HRT) including estrogen and/or progestin, and presence or absence of deleterious BRCA genes. We defined early menarche as age at menarche ≤11 years [22] [23] [24] [25] and late menopause as age at menopause ≥55 years. 26 We categorized people based on the nearest degree relative with a positive history of breast cancer as follows:
(a) Total negative: no family history of breast cancer among any relatives. (b) First-degree positive: a positive family history of breast cancer among first-degree relatives, regardless of whether or not they had a positive history among second or thirddegree relatives. (c) Second/third-degree positive: only a positive history of breast cancer among second or third-degree relatives, but not among first-degree relatives.
We developed the BCS chart using a multiple logistic regression analysis. For this purpose, we generated a set of breast cancer risk factors (age, body mass index, late menopause, having a benign breast disease, and a positive family history of breast cancer in the first-or the second/third-dregree relatives). Then, we combined risk factors with information on the adjusted odds ratios of these risk factors to predict the risk probability of breast cancer for an individual with a given set of characteristics as follows 18 :
In this equation, 'P' is the risk probability of developing breast cancer for an individual. 'b 0 ' is the intercept, that is, the estimated value of P when x = 0. 'b 1 ' is the regression coefficient, that is, the estimated increase in the odds of breast cancer per unit increase in the predictor variable (x). Finally, we stratified and colored the risk probabilities of breast cancer as follows: <05% (green), 05-09% (yellow), 10-14% (orange), 15-19% (red), 20-24% (brown) and ≥25% (black) (Fig. 1) .
We used simple and multiple logistic regression model to assess the association between potential risk factors and breast cancer. We performed all statistical analyses at a significance level of 0.05 using Stata software, version 14 (StataCorp, College Station, TX, USA).
Results
We identified 560 patients with breast cancer, 32 patients had already died, five had migrated elsewhere before an interview could be arranged, and 17 refused the interview. We compared the remaining 506 cases of breast cancer with 916 population-based controls. The mean (SD) age of the cases was 48.37 (10.79) years and that of controls was 42.37 (9.84) years. The characteristics of the case and control groups are given in Table 1 . The cases were older than controls. The prevalence of overweight and obesity, late menopause (≥55 years), a benign breast disease, a positive family history with breast cancer, HRT and deleterious BRCA genes was higher in cases than in controls. On the other hand, the prevalence of early menarche (≤11 years) and age older than 30 years at first birth was higher in controls than in cases.
The association between breast cancer and risk factors are given in logarithmic scale in Table 2 . After controlling for confounding effects of all variables in the table, the results of multiple logistic regression analysis indicated a statistically significant association between breast cancer and age, having a benign breast disease, and a positive history of breast cancer in the first-degree or second/third-degree relatives.
The BCS chart estimating individual risk probability of breast cancer is given in Fig. 1 . The chart provides approximate risk probability of breast cancer, according to age, BMI, late menopause, having a benign breast disease and a positive family history of breast cancer. Based on BCS chart, an individual can be classified in a category of low risk (green), medium risk (yellow and orange), high risk (red and brown) or very high risk (black) for breast cancer. The main message of the BCS chart is that age alone is not a strong predictor of breast cancer. The first column on the left down square of the chart shows the risk probability of breast cancer for different age groups alone without synergistic interaction with other risk factors. All subjects in this column have less than 5% risk (green color) of breast cancer, although their age varies from 30 to 60 years. In other words, subjects in this column are supposed to be free of any risk factors of breast cancer. On the other hand, all individuals in each row of the chart have the same age. Therefore, if we choose any row in the chart, we fix the individuals' age. Regardless of which row we choose, if we go horizontally from the left side of the chart to the right side, we see that the risk of breast cancer increases systematically. This increasing risk from the left to the right side of the e120 JOURNAL OF PUBLIC HEALTH chart is independent of age. This indicates the importance of other risk factors of breast cancer that we should consider when recommending mammography. The chart represents a modeling approach that facilitates making decision on the threshold for recommending screening mammography. The appropriate threshold (10% or 15% risk, for example) depends on the availability of resources in each country or WHO sub-regions.
Discussion
Main finding of this study
The BCS chart, presented in this paper, is a suggested preliminary tool for detecting and stratifying high-risk individuals for developing breast cancer. By detecting high-risk individuals through BCS chart, the program is likely to be far more productive and efficient. Although the chart is not perfect yet due to the paucity and low quality of available data, it can be improved by using data from comprehensive prospective cohort studies. WHO provided a cardiovascular risk prediction chart for each sub-region. Similarly, BCS chart can be adapted for each WHO sub-region, or even each country based on regional and national data. Accordingly, the threshold for recommending screening mammography may vary from region to region according to the situation and the availability of the resources. The appropriate threshold for recommending screening mammography will depend on the economic, political and social realities of each country. If resources allow, the target population can be expanded to include those with moderate levels of risk. For example, very low-income countries, where the shortage of healthcare resources is the main problem, may have to decide to place the threshold for recommending screening mammography at a risk of 20% whereas other countries with additional resources may lower the threshold to 10% or 15%. The level of risk at which screening mammography should be initiated when managing individuals at healthcare facilities is a policy decision that has to be made by health authorities and experts at the national level. These decisions are particularly challenging when public expenditure for health is inadequate. The national health systems will have the difficult task of setting a risk threshold for implementing screening mammography.
What is already known on this topic?
We used several potential risk factors for breast cancer to develop the BCS chart. However, the effect of these risk factors may vary in different settings. For example, evidence based on systematic reviews indicated a significant association between BMI and some gynecologic cancers, such as endometrial and ovarian cancers. 27, 28 The association between BMI and breast cancer varies in the premenopausal and postmenopausal periods. BMI has no significant effect on the incidence of breast cancer during the premenopausal period while having a small effect on the incidence of breast cancer in postmenopausal period. 29 Women whose tests are positive for BRCA genes are at increased risk of breast cancer. 30, 31 Nonetheless, we did not include these genes in the logistic regression analysis because only a limited number of participants were tested for these genes (13 people in the control group and eight people in the case group). Furthermore, we suggested BCS chart for estimating risk of breast cancer in the general population. The results of genetic testing are rarely available for most women, therefore, adding BRCA genes to the BCS chart is not logical.
The mean (SD) age of cases in our study was 48.37 (10.79) years. This is a very young age for cases of breast cancer and is not typical of the age profile of breast cancer cases internationally. A meta-analysis, conducted in Iran in 2016 on 21 epidemiological studies, indicated that the Example: The probability of developing breast cancer in a woman aged 50 years, overweight, with late menopause, with benign beast disease, without family history of breast cancer is calculated as follows: Such a woman will have 19% probability of developing breast cancer, which is specified by red color.
e122 JOURNAL OF PUBLIC HEALTH average age of cases was reported between 40 and 49 years in nine studies, between 50 and 59 in four studies, and 60.3 years in one study. Seven studies did not report the average age of cases. 32 Several other epidemiological studies conducted in Iran reported the average age of cases of breast cancer between 40 and 50 years. [33] [34] [35] [36] The evidence shows that most breast cancers in Iran occur in women over the age of 40, while, a majority of breast cancers in the world are diagnosed after age 50. 37 It is not clear whether breast cancer actually occur a decade sooner in Iranian women compared to the global average age or Iranian older women are under diagnosed.
What this study adds?
Among the risk factors included in the logistic regression model to develop the BCS chart, having a benign breast disease had the strongest association with breast cancer risk. The association between breast cancer and a benign breast disease or a positive family history of breast cancer was much stronger than 10 years of age. This indicates the importance of taking into account not only age but also other risk factors of breast cancer when recommending mammography.
According to our results, in the simple logistic analysis, the proportion of cases who had a young age at menarche was less than controls. This reverse association between early menarche and breast cancer can be explained by the confounding effect of other variables. The common theme with regard to confounding is that the association between an exposure and a given outcome may be strengthened, weakened or eliminated by a confounding variable. 18 In addition, recall bias is another issue that should be addressed. Remembering the age of menarche is prone to recall bias. Women may hardly remember the exact age of menarche. This may explain the reversed association between early menarche and breast cancer.
Limitations of this study
This study had a number of limitations. First, we developed the BCS chart based on data from a local case-control study rather than a national prospective cohort study. The assumption that cases and controls must originate from the same reference population or must originate from populations having similar relevant characteristics is critical in case-control studies. 18 For this purpose, we divided the city into different parts, and performed a stratified random sampling to increase to the similarity of the relevant characteristics among cases and controls. However, case-control studies have their own inherent limitations. Second, we predicted the risk probability of breast cancer based on data from a case-control study rather than a prospective cohort study. Third, due to the limited number our cases aged ≥60 years, we could not extend the BCS chart to the older ages.
Despite these limitations, the BCS chart is a simple tool that can be used by non-physician health workers who are the first contact for healthcare. The tool can be easily used to evaluate and estimate the average risk individuals for breast cancer and take appropriate action according to the national policy. Since the chart uses available and accessible information, it can be applied even in the first-line primary healthcare in low resource settings. By using the chart, a health worker in primary healthcare can measure and classify the average risk individuals for breast cancer and, if necessary, refer them for appropriate action to the next level of care.
Conclusion
BSC chart is a preliminary tool for detecting high-risk individual for developing breast cancer. The main advantage of this chart is its simplicity and flexibility that can be modified and adapted for any situation. BCS chart has been developed just based on history taking in order to be used in far villages with low educated staff and even the general population to motivate them for mammography. By using BCS chart, the screening mammography is targeted to the highrisk population and therefore, it will be more productive and efficient. However, the BCS chart is just a basic and preliminary model that facilitates the decision-making on the threshold for recommending screening mammography. Certainly, this chart is not perfect yet and needs to be refined and adapted to countries or WHO sub-regions. The appropriate threshold for BCS will depend on the availability of resources in each country.
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